<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171216037903N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-05-03</date_registration>
      <primary_sponsor>Qazvin University of Medical Sciences</primary_sponsor>
      <public_title>Effect of illness perception on sexual satisfaction in breast cancer</public_title>
      <acronym></acronym>
      <scientific_title>The effect of illness perception educational intervention's on sexual satisfaction of women with breast cancer</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28274</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The  allocation of random groups with quadruple block's  in two groups(control&amp; intervention).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sexual satisfaction in breast cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Intervention-based illness perception individual(education face-to- face)in3session 30minute every3 weeks will run among themorning shift.First session:meeting of the first after its contact primary with the patient and ask questions about understanding the disease current and their implications,then content of the desired to see the will be. This session based on 5 of illness perception and effects of psychology its Foundation is. This dimensions includes; the nature of the disease(labels and symptoms)due to the beginning disease,understanding one of the disease(time inform the person of the disease),outcom and findings of the expected one of the disease,effective control and treatment and improve disease will be. For intervention illness perception exercises self-control and encouragment verbal and design of objective(like improve sexual satisfaction)feedback and evaluation of  experiences successful people will be used. The second session; after reviewing the training previous patient want the uncertainties and questions possible  about your disease raise. In this session interventions unique based on the need patient set will was training in order to change misunderstanding and negative patients to see the will be. At the end of the second session manual training,including detect and definition of disease,training exercises different physical(such as Kegel) and  recommendations psychological plain language and understandable and based on the latest reference scientific world to seethe will be. Third session;includes evaluation and closing that the  previous session at this meeting to the patient information will be notified first meeting includes review training session previous.Then the patient information impact of training and experience new questions will be. Finally,problems and obstacles forany patients will be. Intervention 2: Control group:Just stages of follow-up after therapy,such as the experimental group send and no training  not  receive.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Abedini Gilani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Qazvin Medical University, Bahonar Blvd, Qazvin</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3415674785</zip>
        <telephone>+98 26 3340 8143</telephone>
        <email>iranabed1234@gmail.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Abedini Gilani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Qazvin Medical University, Bahonar Blvd, Qazvin</address>
        <city>Qazvin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3415674785</zip>
        <telephone>+98 26 3340 8143</telephone>
        <email>iranabed1234@gmail.com</email>
        <affiliation>Qazvin University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Difinite diagnosis of breast cancer
Check out stages of therapeutic
Married
Physical&amp; mental appropriate to responsive</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>53 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of sexual dysfunction before breast cancer
History of psychological disorder before breast cancer
History of any disorder before breast cancer
The presence in an other consultative treatment
Unwillingness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Intervention-based illness perception individual(education face-to- face)in3session 30minute every3 weeks will run among themorning shift.First session:meeting of the first after its contact primary with the patient and ask questions about understanding the disease current and their implications,then content of the desired to see the will be. This session based on 5 of illness perception and effects of psychology its Foundation is. This dimensions includes; the nature of the disease(labels and symptoms)due to the beginning disease,understanding one of the disease(time inform the person of the disease),outcom and findings of the expected one of the disease,effective control and treatment and improve disease will be. For intervention illness perception exercises self-control and encouragment verbal and design of objective(like improve sexual satisfaction)feedback and evaluation of  experiences successful people will be used. The second session; after reviewing the training previous patient want the uncertainties and questions possible  about your disease raise. In this session interventions unique based on the need patient set will was training in order to change misunderstanding and negative patients to see the will be. At the end of the second session manual training,including detect and definition of disease,training exercises different physical(such as Kegel) and  recommendations psychological plain language and understandable and based on the latest reference scientific world to seethe will be. Third session;includes evaluation and closing that the  previous session at this meeting to the patient information will be notified first meeting includes review training session previous.Then the patient information impact of training and experience new questions will be. Finally,problems and obstacles forany patients will be.</i_keyword>
      <i_keyword>Control group:Just stages of follow-up after therapy,such as the experimental group send and no training  not  receive.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sextual satisfaction measured by the Larsson questionnaire. Timepoint: Before intervention and just after intervention. Method of measurement: Larsson sexual satisfaction questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Qazvin University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-01-04</approval_date>
        <contact_name>Ethics committee ofQazvin University of Medical Science</contact_name>
        <contact_address>Golha SQ,Minoodar Ave.,22 Bahman  Blvd., Qazvin Town.,Velayat Hospital Qazvin Qazvin Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
